Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Benzinga Newsdesk www.benzinga.com Negative 75.1%

Neg 75.1% Neu 0% Pos 0%

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.